Where does Fibralign Corporation rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Fibralign Corporation ranks #35,311 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Fibralign Corporation hold?

Fibralign Corporation holds 7 US utility patents granted between 2017 and 2022, spanning 13 technology areas.

What is Fibralign Corporation's Innovation Score?

Fibralign Corporation has an Innovation Score of 33.7 out of 100 (45th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Fibralign Corporation's patent grant rate increasing or decreasing?

Fibralign Corporation's recent grant velocity is -25% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Fibralign Corporation's patents?

Fibralign Corporation's patents average 19.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Fibralign Corporation patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Fibralign Corporation

Q: What technology areas does Fibralign Corporation focus on?

Fibralign Corporation's top technology area is A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles) with 6 patents. Grants appear in 13 CPC subclasses total.

USPTO PatentsView assignee record - 7 granted patents across 13 technology areas, recorded in grant years 2017–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES;).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Fibralign ranks #35,311 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 13 technology areas.

#35,311
of 49,997 US assignees by volume: 45th percentile
by Innovation Score (33.7/100): 19.3
avg claims per patent: -25%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R35311 · US Corporation #35,311 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-MICRO 7 grants
MID-PACK #35,311/49,997
PHOTO-FINISH Feldan Bio
CPC-FOCUS A61L · 13 areas
INNOV-THIN 33.7/100
CLAIMS-RICH 19.3 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -25% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Feldan Bio Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Fibralign · this assignee

34
3D Lighting… · lowest

7

What this shows Fibralign's Innovation Score is 33.7/100 (45th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Fibralign's grants concentrate

Fibralign Corporation is a focused PatentsView assignee: 13 CPC subclasses with 85.7% of grants classified under A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES;). Peak complete grant year is 2018 (2 grants) versus a trough of 1 in 2017. By volume, Fibralign sits between Feldan Bio Inc. and Finzelberg GMBH & Co. KG.

Fibralign's three-year grant acceleration

Fibralign Corporation shows 1 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Feldan Bio

7
Fennec Pharmaceut…

7
Fetch Rewards

7
Figpin Collect Aw…

7
Fibria Celulose S…

7
Filnex

7
Finatec Holding

7
Finzelberg & KG

7
Fibralign ◀

7

What this shows Fibralign holds 7 patents at rank #35,355, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Fibralign

By rank, the assignees closest to #35,355 in granted patent volume.

Leaders in A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects…)

Other assignees with the most granted patents in Fibralign's primary technology class.

Fibralign's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 45th percentile higher than 45% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Fibralign Corporation patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	14.3%
2018	2	28.6%
2019	1	14.3%
2020	1	14.3%
2021	1	14.3%
2022	1	14.3%

Which technologies does Fibralign Corporation patent most?

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 6

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 3

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 3

A61B - DIAGNOSIS; SURGERY; Identification 2

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 2

D01F - Chemical Features IN THE Manufacture OF Artificial Filaments, Threads, Fibres, Bristles OR RIBBONS; Apparatus Specially Adapted FOR THE Manufacture OF Carbon Filaments 2

D01D - Mechanical Methods OR Apparatus IN THE Manufacture OF Artificial Filaments, Threads, Fibres, Bristles OR Ribbons 2

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 2

Y10T - Technical Subjects Covered BY Former US Classification 1

D04H - Making Textile Fabrics, e.g. From Fibres OR Filamentary Material ; Fabrics Made BY Such Processes OR Apparatus, e.g. Felts, Non-woven FABRICS; COTTON-WOOL; Wadding ; ; Non-woven Fabrics From Staple Fibres, Filaments OR Yarns, Bonded With AT Least ONE Web-like Material During Their Consolidation 1

C07K - Peptides 1

D10B - Indexing Scheme Associated With Sublasses OF Section D, Relating TO Textiles 1

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 1

Top 13 of 13 technology areas

Where it ranks

Overall rank by patents

#35,311

of 49,997 tracked assignees

Innovation Score

33.7 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Fibralign Corporation's patent record in context - here's where to go next.

Fibralign Corporation's lead technology class is A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES;), 85.7% of its portfolio - see every assignee active in that class. Explore A61L
Ranked #35,311 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Fibralign Corporation against Feldan Bio Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 33.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.